The two-hour complimentary dinner meeting will feature a presentation by a clinician who is a leading expert on this compelling and highly relevant subject. The presentation will include an overview of bisphosphonates and uses in treatment of osteoporosis and metastatic bone disease, background on osteonecrosis of the jaw (ONJ), a discussion on ONJ frequency in oncology and osteoporosis patients treated with bisphosphonates, and a review of ONJ studies and management.
Benefits of Bisphosphonate Therapy vs. Frequency of Oral Complications
Oct 22nd, 2008
Boston, MA
US
Latest in Conferences
BioHorizons Symposium set for spring
February 13, 2026
Rutgers Health joins FIEFO
February 13, 2026
DEXIS introduces updated DTX Studio
February 12, 2026















